Why AGEN? Agenus Inc. Analysis, Price & AI Insights | Whystock
AGEN
$3.84-0.07 (-1.79%)
Market ClosedLast close May 1
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally.